CIK 0001620463
- Non-accelerated filer
- Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 453368487
- Phone
- +1 425-620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 829 shares (grant or award)
- 4 Grant or award Executive VP, Research acquired 96 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 931 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Operating Officer acquired 50,440 shares (option exercise)
- 4 Exercise or conversion Chief Medical Officer acquired 28,372 shares (option exercise)
- 4 Other disposition Director disposed of 3,000 shares (other)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 1,554 shares (grant or award)
- 4/A Exercise or conversion Vice President of Discovery acquired 3,152 shares (option exercise)
- 4 Exercise or conversion Vice President of Discovery acquired 3,152 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 9 of 11 · 211 filings